China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong · Delayed Price · Currency is HKD 5.16
-0.09 (-1.71%)
May 4, 2026, 4:08 PM HKT
HKG:3320 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Quarter | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 | H2 2021 | H1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | Dec '21 Dec 31, 2021 | Jun '21 Jun 30, 2021 |
Net Income | - | 2,077 | 746.05 | 2,605 | 1,173 | 2,682 | 824.43 | 2,582 | 1,084 | 2,027 |
Depreciation & Amortization | - | 1,888 | 1,729 | 1,628 | 1,635 | 1,530 | 1,141 | 1,368 | 1,187 | 1,135 |
Other Amortization | - | - | - | - | -7.82 | 7.82 | - | - | - | - |
Loss (Gain) From Sale of Assets | - | -3.97 | -49.76 | -20.36 | -63.11 | -0.74 | 24.23 | -346.54 | 0.23 | -8.23 |
Asset Writedown & Restructuring Costs | - | 1,034 | 941.3 | 592.28 | 742.55 | 418.03 | 1,045 | 53.91 | 182.55 | 34.39 |
Loss (Gain) From Sale of Investments | - | -61.25 | -56.81 | -23.08 | 69.22 | -47.88 | 11.51 | -27.92 | -51.34 | -51.36 |
Loss (Gain) on Equity Investments | - | -113.24 | -169.24 | -198.77 | -205.09 | -212.01 | -167.89 | -158.71 | -139.2 | -118.67 |
Stock-Based Compensation | - | 16.44 | 32.44 | 45.88 | 70.38 | 71.51 | 89.94 | 9.28 | 1.17 | - |
Provision & Write-off of Bad Debts | - | 88.87 | 150.33 | 113.47 | 350.09 | 100.58 | 46.51 | 417.15 | 115.6 | 261.01 |
Other Operating Activities | - | 3,251 | 2,890 | 3,746 | 2,222 | 3,414 | 1,528 | 2,742 | 2,419 | 2,251 |
Change in Accounts Receivable | - | -7,041 | 8,047 | -14,961 | 10,877 | -16,954 | 6,910 | -12,885 | 5,841 | -9,892 |
Change in Inventory | - | -2,960 | 210.83 | -5,151 | 1,265 | -3,933 | -1,542 | -666.9 | -770.58 | -2,049 |
Change in Accounts Payable | - | 4,275 | 4,348 | 10,088 | 1,937 | 8,973 | 3,124 | 4,811 | 526.39 | 5,729 |
Change in Unearned Revenue | - | -986.98 | -580.31 | 781.97 | -482.75 | 762.19 | 704.95 | - | 728.41 | - |
Change in Other Net Operating Assets | - | 66.61 | 316.65 | -265.83 | -262.6 | -580.11 | -49.28 | -668.48 | 436.57 | -439.2 |
Operating Cash Flow | - | 1,531 | 18,555 | -1,020 | 19,319 | -3,770 | 13,690 | -2,769 | 11,561 | -1,121 |
Operating Cash Flow Growth | - | - | -3.96% | - | 41.12% | - | 18.42% | - | 67.53% | - |
Capital Expenditures | - | -1,285 | -1,592 | -1,053 | -1,394 | -1,129 | -1,100 | -1,138 | -1,222 | -760.44 |
Sale of Property, Plant & Equipment | - | 67.49 | 121.8 | 61.42 | 153.57 | 23.39 | 63.97 | 8.76 | 92.34 | 25.25 |
Cash Acquisitions | - | -5,007 | -1,514 | -349.08 | -307.15 | 953.68 | 28.61 | -27.62 | -1,402 | -13.58 |
Divestitures | - | 25.78 | -2.87 | 197.66 | 39.85 | - | -68.49 | 473.52 | 178.66 | 12.31 |
Sale (Purchase) of Intangibles | - | -335.51 | -247.75 | -184.54 | -391.62 | -85.3 | -105.21 | -190.42 | -474.17 | -16.44 |
Investment in Securities | - | 939.29 | -1,755 | -2,944 | -2,115 | 1,587 | 999.45 | -706.24 | -2,760 | -1,273 |
Other Investing Activities | - | 577.65 | -438.2 | 810.69 | 1,678 | -1,079 | 802.28 | 190.68 | 859.45 | -791.22 |
Investing Cash Flow | - | -5,017 | -5,427 | -3,460 | -2,337 | 269.69 | 620.63 | -1,390 | -4,723 | -2,822 |
Long-Term Debt Issued | - | 45,690 | - | 46,666 | - | 52,447 | - | 64,066 | - | 43,269 |
Total Debt Issued | - | 45,690 | 33,078 | 46,666 | 32,736 | 52,447 | 24,096 | 64,066 | 34,105 | 43,269 |
Short-Term Debt Repaid | - | - | - | -2,969 | - | -7,562 | - | -4,630 | - | -6,831 |
Long-Term Debt Repaid | - | -39,115 | - | -38,580 | - | -33,436 | - | -51,994 | - | -26,439 |
Total Debt Repaid | - | -39,115 | -44,866 | -41,548 | -46,640 | -40,999 | -35,213 | -56,623 | -38,965 | -33,270 |
Net Debt Issued (Repaid) | - | 6,574 | -11,789 | 5,118 | -13,904 | 11,449 | -11,117 | 7,443 | -4,860 | 9,999 |
Repurchase of Common Stock | - | - | - | - | - | - | -3,018 | - | - | - |
Common Dividends Paid | - | - | -1,489 | - | -879.97 | - | -813.07 | - | - | -626.85 |
Other Financing Activities | - | -1,843 | -5,677 | -3,002 | 387.11 | -1,117 | -9.97 | -1,814 | -1,041 | -851.03 |
Financing Cash Flow | - | 4,731 | -18,954 | 2,116 | -14,397 | 10,331 | -14,958 | 5,628 | -5,901 | 8,521 |
Foreign Exchange Rate Adjustments | - | 4.28 | -40.96 | 5.74 | 0.31 | 9.35 | 742.6 | -685.88 | -509.74 | 218.69 |
Net Cash Flow | - | 1,249 | -5,867 | -2,359 | 2,586 | 6,841 | 95.39 | 784.02 | 427.6 | 4,797 |
Free Cash Flow | - | 246.36 | 16,964 | -2,073 | 17,925 | -4,899 | 12,590 | -3,907 | 10,339 | -1,881 |
Free Cash Flow Growth | - | - | -5.37% | - | 42.38% | - | 21.78% | - | 71.91% | - |
Free Cash Flow Margin | - | 0.19% | 13.14% | -1.61% | 14.71% | -3.99% | 11.77% | -3.64% | 10.38% | -1.98% |
Free Cash Flow Per Share | - | 0.04 | 2.70 | -0.33 | 2.85 | -0.78 | 2.00 | -0.62 | 1.65 | -0.30 |
Cash Interest Paid | - | 1,077 | 926.42 | 1,175 | 1,341 | 1,302 | 734.99 | 1,160 | 1,457 | 720.96 |
Cash Income Tax Paid | - | 1,775 | 1,153 | 1,480 | 941.05 | 1,366 | 954.24 | 1,224 | 627.06 | 1,034 |
Levered Free Cash Flow | 6,335 | -6,335 | 3,703 | -12,290 | 14,052 | -12,293 | 12,025 | -3,559 | 5,220 | -7,812 |
Unlevered Free Cash Flow | 5,707 | -5,707 | 4,382 | -11,555 | 14,638 | -11,402 | 12,797 | -2,840 | 5,857 | -7,053 |
Change in Working Capital | - | -6,646 | 12,342 | -9,508 | 13,334 | -11,732 | 9,147 | -9,409 | 6,762 | -6,651 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.